Table 1.

Patient characteristics (N = 28).

Variables	Total (N = 28)	HT (N = 14)	IMPT (N = 14)	p-Value
Median age, years (range)	50 (37–72)	47 (40–65)	50 (37–72)	0.327
Sex
Female	7 (25.0%)	3 (21.4%)	4 (28.6%)	1
Male	21 (75.0%)	11 (78.6%)	10 (71.4%)
Smoking status
Current or Ex-smoker	11 (39.3%)	6 (42.9%)	5 (35.7%)	1
Non-smoker	17 (60.7%)	8 (57.1%)	9 (64.3%)
Histologic type
Squamous or keratinizing	4 (14.3%)	2 (14.3%)	2 (14.3%)	1
Non-keratinizing	23 (82.1%)	11 (78.6%)	12 (85.7%)
Non-specified	1 (3.6%)	1 (7.1%)	-
cT stage
cT3	19 (67.9%)	6 (42.9%)	13 (92.9%)	0.013
cT4	9 (32.1%)	8 (57.1%)	1 (7.1%)
Tumor extent (involved site)
Intracranial	7 (25.0%)	6 (42.9%)	1 (7.1%)	0.077
Orbital	1 (3.6%)	1 (7.1%)	-
cN stage
0–1	9 (32.1%)	6 (42.9%)	11(78.6%)	1
2–3	19 (67.9%)	8 (57.1%)	3 (21.4%)
Clinical stage
III	17 (60.7%)	6 (42.9%)	11 (78.6%)	0.122
IV	11 (39.3%)	8 (57.1%)	3 (21.4%)
Induction chemotherapy
Not carried out	24 (85.7%)	11 (78.6%)	13 (92.9%)	0.596
Carried out	4 (14.3%)	3 (21.4%)	1 (7.1%)